Alzheimer’s disease

  • M/F
  • 18 - 55 years old
  • Non-smoker
  • Healthy

Clinical trial of a new compound that is being developed for the treatment of Alzheimer’s disease

Very positive, professional and a nice location.


Participant ICON

Find out if you qualify for this trial

  • You are a healthy male or female
  • You are between 18 and 55 years old
  • You weigh more than 50 kg
  • Your Body Mass Index (BMI) is between 18.5 and 32 kg/m2
  • Non-smoker

Good to know about this trial

  • The study compound is administered via a tablet.
  • The medical sreening takes place in Groningen or Utrecht
  • With your participation you help people with Alzheimer's disease

Download the complete research overview

How does it work

How does it work?

Read more

Study groups

Register without obligation for the group of your preference


Additional information

In this study we will compare how quickly and to what extent three different tablets of the study compound are absorbed, transported, and eliminated from the body. This will be done by looking at the amount of the study compound in the blood after intake of the different tablets. The tablets have different strengths and are manufactured in different ways. We will also investigate how safe the new compound is and how well it is tolerated when it is administered to healthy participants.


Target group

  • You are a healthy male or female.
  • You are at least 18 and no more than 55 years old.
  • You weigh at least 50 kg and your Body Mass Index (BMI) is higher than or equal to 18.5 and lower than or equal to 32.0 kg/m2. The BMI shows the relationship between body weight in kilograms and height in meters.
  • You did not smoke, vape, or use nicotine patches or sprays, and nicotine chewing gum in the 3 months prior to screening.


  • You cannot participate in the trial if you have participated in another clinical trial in the 30 days prior to the first study drug administration in this clinical trial (counting from the follow-up visit of the previous trial). This might be longer for certain trials, please contact us for more information.
  • To determine if you are suitable to participate in this trial, you will undergo a medical screening. 

As a female you can only participate if you are not pregnant, not breast feeding, and meet one of the following conditions:

  • You use contraception (for example the contraceptive pill or intra-uterine device) in combination with a condom;
  • You have passed the menopause (no periods for at least 12 months);
  • You have been sterilized or your male partner has been sterilized;
  • You are only sexually active with a partner of the same sex;
  • You are not sexually active according to your lifestyle.

As a male you can only participate if you meet one of the following conditions:

  • You use a condom in combination with an additional contraception method used by your female partner;
  • You have been sterilized and you are using a condom with your female partner;
  • Your female partner is sterilized or has passed the menopause (no periods for at least 12 months);
  • You are only sexually active with a partner of the same sex;
  • You are not sexually active according to your lifestyle.



You will receive a gross compensation of € 3599 for full participation in one of the cohorts.

Travel expenses will be reimbursed based on the distance traveled (€ 0.21 net per kilometer) with a minimum of € 13 and a maximum of € 176.40 (840 kilometers) per round trip, regardless of the mode of transportation.


Period of stay and research

The trial consists of 3 periods during which you will stay in the research facility in Groningen for 5 days (4 nights) per period. The follow-up visit will take place between 2 to 4 days after your last departure from the research facility.

Note: You must be available for all dates to be able to participate in this clinical trial. The location in Groningen is Van Swietenlaan 6.

Frequently asked questions

You can participate in a trial a maximum of four times a year. There must be at least 30 days between two trials. Some trials have a longer waiting period.

During the trial, you may suffer from mild symptoms like headache or nausea. That may be caused by the medication. It might also be caused by needing to fast for the trial, for example. Those side effects are no fun, but fortunately are not dangerous.

Before a medication is tested on people, it has already been studied extensively in a lab. This enables us to predict well which side effects you might get and we can prepare you for them. It almost never happens that participants suffer from unexpected side effects. For example, an allergic reaction to the medication occurs on average once a year.

Your participation in a clinical trial is always voluntary. You can therefore decide to stop at any time. Sometimes you have to stop. For example because of family circumstances or if the doctor decides it is better for your health. If you stop, we will look at what portion of the compensation you are entitled to. It's only fair!

We pay the compensation for your participation, including travel expenses, within 21 days of the follow-up screening of the trial. If you have questions about the payment, please contact us.

Current trials

Participate in another study?

View all clinical trials
View all clinical trials